Yakira Capital Management, Inc. - CLARUS THERAPEUTICS HLDNGS I ownership

Back to all holdings Add to watchlist

CLARUS THERAPEUTICS HLDNGS I's ticker is and the CUSIP is 18271L115. A total of 18 filers reported holding CLARUS THERAPEUTICS HLDNGS I in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
Quarter-by-quarter ownership
Yakira Capital Management, Inc. ownership history of CLARUS THERAPEUTICS HLDNGS I
ValueSharesWeighting
Q2 2022$10,000
-47.4%
127,4970.0%0.00%
-33.3%
Q1 2022$19,000
-48.6%
127,4970.0%0.00%
-40.0%
Q4 2021$37,000
-65.7%
127,497
-11.5%
0.01%
-70.6%
Q3 2021$108,000–144,097–0.02%–
 Download
Other shareholders

There were no reported owners of CLARUS THERAPEUTICS HLDNGS I in Q1 2022.

NameSharesValueWeighting ↓
View complete list of CLARUS THERAPEUTICS HLDNGS I shareholders